Overview
Donyarat Ruenmarkkaew practices practicing medicine in Chiang Mai, Thailand.
Their clinical expertise encompasses Milk-Alkali Syndrome, Hypercalcemia, and Tongue Cancer.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Donyarat Ruenmarkkaew
Is Donyarat Ruenmarkkaew a top-rated expert for Milk-Alkali Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Donyarat Ruenmarkkaew is classified as an Experienced expert for Milk-Alkali Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Donyarat Ruenmarkkaew participate in research or clinical trials?
Yes. Donyarat Ruenmarkkaew has published 12 articles and abstracts on conditions like Milk-Alkali Syndrome. You can view a list of Donyarat Ruenmarkkaew's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- HypercalcemiaRuenmarkkaew isExperienced. Learn about Hypercalcemia.
- Milk-Alkali SyndromeRuenmarkkaew isExperienced. Learn about Milk-Alkali Syndrome.
- Tongue CancerRuenmarkkaew isExperienced. Learn about Tongue Cancer.